|1.||Liou, Shu-Fen: 6 articles (02/2013 - 11/2004)|
|2.||Yeh, Jwu-Lai: 6 articles (02/2013 - 11/2004)|
|3.||Chen, Ing-Jun: 6 articles (02/2013 - 11/2004)|
|4.||Liang, Jyh-Chong: 3 articles (02/2013 - 11/2004)|
|5.||Hsu, Jong-Hau: 2 articles (02/2013 - 08/2011)|
|6.||Wu, Jiunn-Ren: 2 articles (08/2011 - 03/2005)|
|7.||Chiu, Chaw-Chi: 2 articles (08/2006 - 11/2004)|
|8.||Chen, Huai-Min: 1 article (08/2011)|
|9.||Dai, Zen-Kong: 1 article (08/2011)|
|10.||Lin, Hung-Hong: 1 article (02/2009)|
11/01/2004 - "These results indicate that labedipinedilol-A may inhibit cell proliferation by attenuating activation of the ERK 1/2 pathway, which is regulated by PKC and Ca, suggesting that it may have great potential in the prevention of progressive atherosclerosis."
08/01/2011 - "Thus, labedipinedilol-A may have a valuable role in the preventing atherosclerosis associated with hyperlipidemia."
|2.||Myocardial Ischemia (Ischemic Heart Diseases)
|4.||Vascular Diseases (Vascular Disease)
|5.||Prostatic Neoplasms (Prostate Cancer)
02/04/2009 - "Here, we report that treatment of androgen-sensitive (LNCaP) and androgen-insensitive (PC-3) prostate cancer cells with labedipinedilol-A inhibited cell proliferation in concentration-dependent and time-dependent manners. "
02/04/2009 - "In this research, we conducted an in vitro analysis to evaluate the prostate cancer cells response to labedipinedilol-A in order to determine the effect of this selective alpha(1)-adrenoceptor antagonist to suppress prostate cancer cell growth by affecting cell proliferation and apoptosis. "
02/04/2009 - "Inhibition of human prostate cancer cells proliferation by a selective alpha1-adrenoceptor antagonist labedipinedilol-A involves cell cycle arrest and apoptosis."
|2.||HMGB1 Protein (HMG1)
|3.||Calcium Channels (Calcium Channel)